Does Lowering Plasma Homocysteine Reduce Vascular Disease Risk?
- 27 April 2009
- journal article
- review article
- Published by Oxford University Press (OUP)
- Vol. 59 (7) , 242-244
- https://doi.org/10.1111/j.1753-4887.2001.tb07016.x
Abstract
A recent study indicates that lowering homocysteine with folic acid and vitamin B6 significantly reduces the incidence of abnormal exercise electrocardiography tests and thus decreases the risk of atherosclerotic disease. Questions about study design and sample size, however, suggest that this conclusion may be premature.Keywords
This publication has 8 references indexed in Scilit:
- Homocysteine: A History in ProgressNutrition Reviews, 2000
- Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trialThe Lancet, 2000
- Endpoints for homocysteine-lowering trialsThe Lancet, 2000
- An Overview of the Homocysteine Lowering Clinical TrialsPublished by Springer Nature ,2000
- Homocysteine and Endothelial DysfunctionPublished by Springer Nature ,2000
- Homocysteine and Coagulation Factors: Basic Interactions and Clinical StudiesPublished by Springer Nature ,2000
- Homocysteine and Cholesterol: Basic and Clinical InteractionsPublished by Springer Nature ,2000
- Carotid Intima-Media Thickness Is Only Weakly Correlated With the Extent and Severity of Coronary Artery DiseaseCirculation, 1995